CLYM 10-Q: SEC filing
Climb Bio, Inc.
Filed with the SEC on · accession 0001193125-26-448567
CLYM filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -4.9% by the first close after the filing.
Summary of the filing
Climb Bio, Inc. filed its quarterly report on Form 10-Q for the period ending September 30, 2026, reporting financial results and business updates including its pipeline programs and license agreements.
Key details
How CLYM stock reacted
Close before
$9.33
Nov 4, 2026
First close after
-4.93%
$8.87
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CLYM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CLYM?
Click hereFrequently asked questions
What did CLYM file with the SEC on Nov 5, 2026?
CLYM filed a 10-Q (SEC filing). Climb Bio, Inc. filed its quarterly report on Form 10-Q for the period ending September 30, 2026, reporting financial results and business updates including its pipeline programs and license agreements.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did CLYM stock react to this filing?
CLYM closed at $9.33 before the filing and $8.87 on Nov 5, 2026 (-4.93%).
Other CLYM SEC filings
- 8-K · SEC filingNov 5, 2026
- 8-K · Fda approvalOct 26, 2026
- 8-K · Fda approvalOct 23, 2026
- 8-K · Fda approvalSep 3, 2026
- 8-K · SEC filingAug 14, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · SEC filingAug 6, 2026
- 8-K · Board changeJul 1, 2026
- 144 · Insider sale plannedJun 30, 2026
- 424B5 · Secondary offeringJun 12, 2026
Get alerts when CLYM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days